KOBUK THERAPEUTICS
Live / Allowed — Notice of allowance issued (as of 31 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 27 Mar 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99107436
- Mark type
- Stylized text
- Filed
- 27 Mar 2025
- Published for opposition
- 03 Feb 2026
- Attorney of record
- Joseph W. Ricigliano
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
- Class 042 — Scientific and technological services: Development of pharmaceutical preparations and medicines
Owner
- Kobuk Therapeutics Inc., Boston, MA, US
- Kobuk Therapeutics Inc., Boston, MA, US
Prosecution history
- 31 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Feb 2026 — PUBLISHED FOR OPPOSITION
- 28 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 05 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 14 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 14 Oct 2025 — NON-FINAL ACTION E-MAILED
- 14 Oct 2025 — NON-FINAL ACTION WRITTEN
- 07 Oct 2025 — ASSIGNED TO EXAMINER
- 06 Oct 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 27 Mar 2025 — APPLICATION FILING RECEIPT MAILED
- 27 Mar 2025 — NEW APPLICATION ENTERED